Is vaginal estrogen associated with cardiovascular risk or blood clot risk in women with a personal history of blood clots?
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901823764299776 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The literature indicates that vaginal estrogen therapy has low systemic absorption and is not linked to increased risk of venous thromboembolism or cardiovascular issues, including in women with a history of blood clots. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18366951 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Is vaginal estrogen associated with cardiovascular risk or blood clot risk in women with a personal history of blood clots? Tripdatabase vaginal estrogen associated cardiovascular risk blood clot women personal history clots The literature indicates that vaginal estrogen therapy has low systemic absorption and is not linked to increased risk of venous thromboembolism or cardiovascular issues, including in women with a history of blood clots. |
| title | Is vaginal estrogen associated with cardiovascular risk or blood clot risk in women with a personal history of blood clots? |
| topic | vaginal estrogen associated cardiovascular risk blood clot women personal history clots |
| url | https://doi.org/10.5281/zenodo.18366951 |